Tvardi Therapeutics (TVRD) Non-Current Assets (2013 - 2026)

Tvardi Therapeutics (TVRD) posted Non-Current Assets of $491000.0 for Q1 2026, down 8.22% sequentially from $535000.0 in Q4 2025.

Tvardi Therapeutics (TVRD) Non-Current Assets (2013 - 2026) Analysis & Trends

Tvardi Therapeutics has reported Non-Current Assets for 14 years, with the latest figure at $491000.0 in Q1 2026.

Quarterly Non-Current Assets changed N/A year-over-year to $491000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (changed N/A YoY) and the FY2025 annual result came in at $535000.0, down 84.77% from the prior year.
Non-Current Assets slipped to $491000.0 in Q1 2026 per TVRD's latest filing, from $535000.0 in the prior quarter.
Over five years, Non-Current Assets peaked at $72.1 million in Q1 2022 and troughed at $491000.0 in Q1 2026.
A 5-year average of $14.6 million and a median of $9.3 million in 2023 frame the typical range for Non-Current Assets.
The sharpest annual moves came in 2022 and 2025: Non-Current Assets rose 16.53% in 2022, then slumped 92.82% in 2025.
Over 5 years, Non-Current Assets stood at $13.3 million in 2022, then decreased by 27.32% to $9.7 million in 2023, then sank by 63.73% to $3.5 million in 2024, then slumped by 84.77% to $535000.0 in 2025, then slipped by 8.22% to $491000.0 in 2026.
According to Business Quant data, Non-Current Assets over the past three periods registered $491000.0, $535000.0, and $578000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Assets (Qtr)
1	Vertex Pharmaceuticals	139.09 Bn	131.23 Bn	2.84 Bn	14.88 Bn
2	Regeneron Pharmaceuticals	85.66 Bn	77.66 Bn	3.93 Bn	23.28 Bn
3	Argenx Se	64.86 Bn	59.67 Bn	1.37 Bn	1.96 Bn
4	Moderna	58.07 Bn	52.93 Bn	52.00 Mn	5.15 Bn
5	BeOne Medicines	41.87 Bn	36.77 Bn	1.53 Bn	1.96 Bn
6	Alnylam Pharmaceuticals	31.45 Bn	28.15 Bn	992.69 Mn	938.60 Mn
7	BioNTech SE	27.90 Bn	9.51 Bn	668.28 Mn	6.80 Bn
8	Insmed	27.40 Bn	26.24 Bn	358.27 Mn	468.65 Mn
9	Royalty Pharma	27.28 Bn	26.45 Bn	-	18.06 Bn
10	Tvardi Therapeutics	17.56 Mn	17.56 Mn	-	448,000.00

Download Data